Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: The Endothelial Modulation in Angiogenic Therapy randomized controlled trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 4, 2008, Pages

  Ruel, Marc ^a   Beanlands, Robert S ^a   Lortie, Mireille ^a   Chan, Vincent ^a   Camack, Nancy ^b   deKemp, Robert A ^a   Suuronen, Erik J ^a   Rubens, Fraser D ^a   DaSilva, Jean N ^a   Sellke, Frank W ^c   Stewart, Duncan J ^b   Mesana, Thierry G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; ARGININE; PLACEBO; VASCULOTROPIN 165;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 40949152736     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.09.073     Document Type: Article

References (25)

1. Quyyumi A.A., Dakak N., Mulcahy D., Andrews N.P., Husain S., Panza J.A., et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 29 (1997) 308-317
2. Zeiher A.M., Schachlinger V., Hohnloser S.H., Saurbier B., and Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 89 (1994) 2525-2532
3. Berkenboom G., Crasset V., Giot C., Unger P., Vachiery J.L., and LeClerc J.L. Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant recipients. Am Heart J 135 (1998) 488-494
4. Ruef J., Marz W., and Winkelmann B.R. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study). Scand Cardiovasc J 40 (2006) 274-279
5. Ruel M., Wu G.F., Khan T.A., Voisine P., Bianchi C., Li J., et al. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model. Circulation 108 Suppl 1 (2003) II335-II340
6. Babaei S., Teichert-Kuliszewska K., Zhang Q., Jones N., Dumont D.J., and Stewart D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162 (2003) 1927-1936
7. Duan J., Murohara T., Ikeda H., Katoh A., Shintani S., Sasaki K., et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 102 (2000) III370-III376
8. Kapila V., Sellke F.W., Suuronen E.J., Mesana T.G., and Ruel M. Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?. Expert Opin Investig Drugs 14 (2005) 37-44
9. O'Neill IV T.J., Wamhoff B.R., Owens G.K., and Skalak T.C. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97 (2005) 1027-1035
10. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116 (2006) 1865-1877
11. Jang J.J., Ho H.K., Kwan H.H., Fajardo L.F., and Cooke J.P. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 102 (2000) 1414-1419
12. Voisine P., Li J., Bianchi C., Khan T.A., Ruel M., Xu S.H., et al. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction. Circulation 112 (2005) I202-I207
13. Voisine P., Bianchi C., Khan T.A., Ruel M., Xu S.H., Feng J., et al. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction. J Thorac Cardiovasc Surg 129 (2005) 1414-1420
14. Lerman A., Burnett Jr. J.C., Higano S.T., McKinley L.J., and Holmes Jr. D.R. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97 (1998) 2123-2128
15. Tousoulis D., Davies G.J., Tentolouris C., Crake T., Katsimaglis G., Stefanadis C., et al. Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries. Am J Cardiol 82 (1998) 1110-1113 A6
16. Lekakis J.P., Papathanassiou S., Papaioannou T.G., Papamichael C.M., Zakopoulos N., Kotsis V., et al. Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. Int J Cardiol 86 (2002) 317-323
17. Koifman B., Topilski I., Megidish R., Zelmanovich L., Chernihovsky T., Bykhovsy E., et al. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease. Am J Cardiol 98 (2006) 172-177
18. Ruel M., Laham R.J., Parker J.A., Post M.J., Ware J.A., Simons M., et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 124 (2002) 28-34
19. deKemp R.A., and Nahmias C. Automated determination of the left ventricular long axis in cardiac positron tomography. Physiol Meas 17 (1996) 95-108
20. Beanlands R.S., Muzik O., Melon P., Sutor R., Sawada S., Muller D., et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 26 (1995) 1465-1475
21. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
22. Yoshinaga K., Chow B.J., dekemp R.A., Thorn S., Ruddy T.D., Davies R.A., et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 11 (2005) 903-932
23. Schulman S.P., Becker L.C., Kass D.A., Champion H.C., Terrin M.L., Forman S., et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 295 (2006) 58-64
24. Ziche M., Morbidelli L., Choudhuri R., Zhang H.T., Donnini S., Granger H.J., et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99 (1997) 2625-2634
25. Peretz A., Leotta D.F., Sullivan J.H., Trenga C.A., Sands F.N., Aulet M.R., et al. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord 7 (2007) 11